Biotech

All Articles

Zephyrm seeks Hong Kong IPO to cash phase 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submitting (PDF) for an...

Frazier Lifestyle Sciences collects $630M for little, mid-cap biotechs

.Frazier Life Sciences has actually sourced a better $630 million for its own fund concentrated on l...

GigaGen achieves approximately $135M BARDA bucks to hammer botulism

.Antitoxin connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its ...

GPCR company Septerna files for IPO on stamina of preclinical records

.Septerna will learn how a biotech without "any sort of meaningful medical information" meals in the...

Kurma shuts to begin with $154M payload for largest biotech fund yet

.International VC company Kurma Partners has actually introduced its own newest biotech fund, with 1...

Prothena markets one exec while another leaves-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, shooting...

Editas cashes in on Vertex Cas9 licensing rights for $57M

.Versus the backdrop of a Cas9 patent war that declines to die, Editas Medication is actually cashin...

Ultragenyx changes genetics therapy application to dial up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson ailment gene treatment UX701 have ...

Biopharma layoff cost maintains in Q3: Strong Biotech evaluation

.As summer months warm turns to cool winds, hopes that this year would certainly deliver prevalent b...

J &amp J drops period 2 dengue prospect in latest switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its own contagious illness pipeline has actually asserte...